Jefferies Group's GH Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 69,899 shares of Guardant Health, Inc. (GH) worth $4.37 M, representing 0.02% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Jefferies Group has maintained this position in GH for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 67,796 shares. Largest reduction occurred in Q4 2024, reducing 300 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2024 | +300 | New Buy | 300 | $22.94 |
| Q4 2024 | -300 | Sold Out | 0 | $0.00 |
| Q2 2025 | +2,103 | New Buy | 2,103 | $52.04 |
| Q3 2025 | +67,796 | Add 3223.78% | 69,899 | $62.48 |
Jefferies Group's Guardant Health Investment FAQs
Jefferies Group first purchased Guardant Health, Inc. (GH) in Q3 2024, acquiring 300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Guardant Health, Inc. (GH) for 4 quarters since Q3 2024.
Jefferies Group's largest addition to Guardant Health, Inc. (GH) was in Q3 2025, adding 69,899 shares worth $4.37 M.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 69,899 shares of Guardant Health, Inc. (GH), valued at approximately $4.37 M.
As of the Q3 2025 filing, Guardant Health, Inc. (GH) represents approximately 0.02% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Guardant Health, Inc. (GH) was 69,899 shares, as reported at the end of Q3 2025.